摘要
目的:探究和分析社区慢病管理对高血压病患者规范用药的效果,为临床相关治疗提供依据。方法:选取宁德市医院全科基地协作单位蕉南社区卫生服务中心门诊2016年2月-2017年2月收治的150例高血压患者作为研究对象,随机分为观察组和对照组,各75例。对照组接受常规血压控制治疗,在此基础上,观察组给予慢病管理规范化用药。比较两组患者的血压控制情况、并发症发生情况及生活质量。结果:治疗后,两组患者的血压均有所下降,且观察组明显优于对照组,差异均有统计学意义(P<0.01)。观察组血压控制率为93.33%,明显高于对照组的66.67%,差异有统计学意义(P<0.01)。观察组并发症发生率明显低于对照组,生活质量评分明显高于对照组,差异均有统计学意义(P<0.01)。结论:社区高血压病患者实行慢病管理的疗效显著,通过规范用药指导和健康干预可有效控制患者血压,减少并发症的发生,提高生活质量,值得进一步推广应用。
Objective:To explore and analyze the effect of chronic disease management in community on standardized medication in patients with hypertension and provide basis for clinical treatment.Method:A total of 150 hypertensive patients admitted to Ningde Municipa Hospital general base collaborative unit of Jiaonan Community Health Service Center from February 2016 to February 2017 were selected as the objects of study and randomly divided into the observation group and the control group,75 cases in each group.The control group received routine blood pressure control treatment.On this basis,the observation group was given chronic disease management on standardized medication.The control of blood pressure,the occurrence of complications and the quality of life of the two groups were compared.Result:After treatment,Blood pressure in both groups were decreased,and the blood pressure in the observation group were significantly better than those in the control group,the differences were statistically significant(P<0.01).The blood pressure control rate in the observation group was 93.33%,which was significantly higher than 66.67%in the control group,the difference was statistically significant(P<0.01).Compared with the control group,the complication rate was lower,and the quality of life scores were higher in the observation group,the differences were statistically significant(P<0.01).Conclusion:Chronic disease management for patients with hypertension in community has a significant curative effect,it can effectively control the blood pressure,reduce the occurrence of complications,and improve the quality of life by standardized medication guidance and health intervention,and is worthy of further promotion and application.
作者
汤一榕
郑庆顺
朱绍亨
宋一帆
陈琦
叶太明
TANG Yirong;ZHENG Qingshun;ZHU Shaoheng(Ningde Municipa Hospital Affiliated to Fujian Medical University,Ningde 352100,China)
出处
《中外医学研究》
2018年第19期5-7,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
慢病管理
高血压
规范用药
Chronic disease management
Hypertension
Standardized medication